$5.5M in support from Snow Medical to CREID & APPRISE for COVID-19 research

The Snow Medical Research Foundation (Snow Medical) is providing $5.5 million in funding to CREID and our partner CRE APPRISE for priority COVID-19 research projects. These projects target the critical answers we need as a nation to return to work quickly and safely, and to rebuild our economy.

CREID Director, Prof Tania Sorrell said: “Critically, the vision of Snow Medical has enabled CREID and APPRISE to leverage the joint power of their national research networks in the fight against COVID-19.”

Funding will be deployed to these four priority projects:

1. State-of-the-art data science and imaging analysis using artificial intelligence and machine learning to build a secure, national electronic data analytics platform, led by Prof Tom Snelling from the University of Sydney

2. Faster, more accurate national tracking of the spread of COVID-19. This will provide greater detail about COVID-19 infection within the Australian community. This project is led by Prof Kristine Macartney from the National Centre for Immunisation Research and Surveillance

3. A national biobank of highly characterised samples from symptomatic and asymptomatic COVID-19 positive individuals, jointly led by a national consortium of researchers from the University of Melbourne, UNSW and The University of Sydney

4. Blood and genetic markers of COVID-19 to accurately measure illness severity and predict the risk of becoming seriously ill, led by Associate Professor Benjamin Tang from Westmead Institute of Medical Research.

Featured Posts
Recent Posts

NHMRC Centre of Research Excellence in Emerging Infectious Diseases

Westmead Institute for Medical Research

176 Hawkesbury Road, Westmead | NSW | 2145 

e: mbi@sydney.edu.au

p: +61 2 8627 3402